User profiles for Makuza Jean Damascene
Jean Damascene MakuzaPhD student-School of Population and Public Health, University of British Columbia Verified email at bccdc.ca Cited by 615 |
Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda
JD Makuza, S Nsanzimana, MA Muhimpundu… - Pan African Medical …, 2015 - ajol.info
Introduction: Cervical cancer prevalence in Rwanda has not been well-described. Visual
inspection with acetic acid or Lugol solution has been shown to be effective for cervical cancer …
inspection with acetic acid or Lugol solution has been shown to be effective for cervical cancer …
Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir–sofosbuvir (SHARED): a single-arm trial
…, F Kateera, G Camus, MJ Damascene… - The lancet …, 2019 - thelancet.com
Background Limited treatment data are available for hepatitis C virus (HCV) in sub-Saharan
Africa, especially for genotype 4. Our objective was to establish the safety and efficacy of …
Africa, especially for genotype 4. Our objective was to establish the safety and efficacy of …
Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda
Background The epidemiology of hepatitis B virus (HBV) infection in the general population
in Rwanda is not well known. This study examined the prevalence of HBV surface antigen (…
in Rwanda is not well known. This study examined the prevalence of HBV surface antigen (…
Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment …
…, A Murangwa, J Serumondo, JD Makuza… - The Lancet …, 2022 - thelancet.com
Background Hepatitis C virus (HCV) genotype 4 non-a/d subtypes, which frequently have
NS5A resistance-associated substitutions, are highly prevalent in sub-Saharan Africa. These …
NS5A resistance-associated substitutions, are highly prevalent in sub-Saharan Africa. These …
The cascade of care for hepatitis C treatment in Rwanda: a retrospective cohort study of the 2017–2019 mass screening and treatment campaign
Access to hepatitis C (HCV) testing and treatment is still limited globally. To address this, the
Government of Rwanda launched a voluntary mass screening and treatment campaign in …
Government of Rwanda launched a voluntary mass screening and treatment campaign in …
Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program
Background The epidemiology and risk factors for hepatitis C virus (HCV) infection in Rwanda
are not well known; however, this information is crucial to shaping the country’s public …
are not well known; however, this information is crucial to shaping the country’s public …
[HTML][HTML] Controlling hepatitis C in Rwanda: a framework for a national response
…, J Mugabo, M Mwumvaneza, JD Makuza… - Bulletin of the World …, 2018 - ncbi.nlm.nih.gov
With the introduction of direct-acting antiviral drugs, treatment of hepatitis C is both highly
effective and tolerable. Access to treatment for patients, however, remains limited in low-and …
effective and tolerable. Access to treatment for patients, however, remains limited in low-and …
Predictors of mortality in a paediatric intensive care unit in Kigali, Rwanda
…, AC Karambizi, JC Kabayiza, JD Makuza… - Paediatrics and …, 2017 - Taylor & Francis
Background: The enormous burden of critical illness in resource-limited settings has led to a
growing interest in paediatric critical care in these regions. However, published data on the …
growing interest in paediatric critical care in these regions. However, published data on the …
The association between HIV self-test awareness and recent HIV testing uptake in the male population in Gambia: data analysis from 2019–2020 demographic and …
Background The Gambian Ministry of Health is supportive of HIV self-testing (HIVST) and
HIVST initiatives are being piloted as an additional strategy to increase HIV testing for …
HIVST initiatives are being piloted as an additional strategy to increase HIV testing for …
Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study
Introduction As part of the integration of refugees into Rwanda’s national hepatitis C elimination
agenda, a mass screening campaign for hepatitis B (HBV) and hepatitis C (HCV) was …
agenda, a mass screening campaign for hepatitis B (HBV) and hepatitis C (HCV) was …